This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Envirotainer's management team will be investing alongside AAC.
Envirotainer designs, manufactures and rents out specialist air cargo containers for the transportation of temperature sensitive pharmaceuticals. Headquartered in Lagga, Sweden, the business has grown substantially to form a strong worldwide presence since it was first established in 1984. Today, the business covers the major trade routes for biological pharmaceuticals, with service hubs in 26 countries and sales around •‚¬31 million.
Commenting on the acquisition, David Holm-Ovren, partner at AAC Capital Partners in the Nordics, said:
“Led by a seasoned management team, Envirotainer has established itself as the clear market leader in a high growth sector. We see significant growth in the biological pharmaceuticals industry and believe that there is a concurrent growing need for temperature controlled transport going forward.”
Anders Eklund, investment director at Industrifonden, said:
"For Industrifonden, this investment is doubly satisfying. For five years, we have played a leading role in refinancing and building the company together with its board of directors and management and, in addition, have earned a nice profit. With AAC Capital Partners as an owner, the company has the opportunity to continue its development and international expansion.”
Thomas Persson, CEO of Envirotainer, said: “We look forward to working with AAC to grow the business in the coming years. There is a significant opportunity to expand the business to the benefit of our customers in the next few years and we are delighted to partner with AAC's expertise to help us deliver it.”
Envirotainer designs, manufactures and rents out specialist air cargo containers for the transportation of temperature sensitive pharmaceuticals. Headquartered in Lagga, Sweden, the business has grown substantially to form a strong worldwide presence since it was first established in 1984. Today, the business covers the major trade routes for biological pharmaceuticals, with service hubs in 26 countries and sales around •‚¬31 million.
Commenting on the acquisition, David Holm-Ovren, partner at AAC Capital Partners in the Nordics, said:
“Led by a seasoned management team, Envirotainer has established itself as the clear market leader in a high growth sector. We see significant growth in the biological pharmaceuticals industry and believe that there is a concurrent growing need for temperature controlled transport going forward.”
Anders Eklund, investment director at Industrifonden, said:
"For Industrifonden, this investment is doubly satisfying. For five years, we have played a leading role in refinancing and building the company together with its board of directors and management and, in addition, have earned a nice profit. With AAC Capital Partners as an owner, the company has the opportunity to continue its development and international expansion.”
Thomas Persson, CEO of Envirotainer, said: “We look forward to working with AAC to grow the business in the coming years. There is a significant opportunity to expand the business to the benefit of our customers in the next few years and we are delighted to partner with AAC's expertise to help us deliver it.”
Companies in this press-release
